Promoter hypermethylation: a new therapeutic target emerges in urothelial cancer.
Cote
Richard J
RJ
Laird
Peter W
PW
Datar
Ram H
RH
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D018899:CpG Islands; D019175:DNA Methylation; D006801:Humans; D011401:Promoter Regions, Genetic; D014571:Urologic Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology